On Friday, Shares of Sirius XM Holdings Inc. (NASDAQ:SIRI), lost -1.30% to $3.81.
Sirius XM Canada declared the most comprehensive coverage of the NFL available on any audio platform throughout the 2015 season, featuring live broadcasts of every game plus daily NFL talk on the SiriusXM NFL Radio channel (available to all Sirius subscribers, in addition to XM Premier subscribers).
Throughout the season all NFL games through Super Bowl 50 air on satellite radios. Subscribers to the SiriusXM All Access package – which comprises satellite radio and internet listening – can also listen to every game via the SiriusXM app and at SiriusXM.ca. Weekly NFL plans with SiriusXM channel assignments can be found at www.siriusxm.ca/sports/nfl.
SiriusXM NFL Radio (channel 88), the only 24/7 radio channel dedicated to the NFL, enters its 12th season on the air and continues to offer the most comprehensive and in-depth audio coverage of the league.
Sirius XM Holdings Inc., through its auxiliaries, provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, counting various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and local traffic reports for 22 metropolitan markets.
Shares of Gilead Sciences Inc. (NASDAQ:GILD), inclined 2.22% to $109.63, during its last trading session.
Gilead Sciences declared the pricing of senior unsecured notes in an aggregate principal amount of $10 billion, in an underwritten, registered public offering, compriseing of six tranches:
- $1,000 million of 1.850% senior notes maturing in 2018
- $2,000 million of 2.550% senior notes maturing in 2020
- $1,000 million of 3.250% senior notes maturing in 2022
- $2,750 million of 3.650% senior notes maturing in 2026
- $1,000 million of 4.600% senior notes maturing in 2035
- $2,250 million of 4.750% senior notes maturing in 2046
The senior notes are rated A- by Standard & Poor’s and A3 by Moody’s. The offering is predictable to close September 14, 2015, subject to customary closing conditions.
Gilead intends to use the net proceeds from the offering for general corporate purposes, which may comprise the repayment of debt, working capital, payment of dividends and the repurchase of its outstanding common stock following its authorized share repurchase program.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific.
Finally, Ambarella, Inc. (NASDAQ:AMBA), ended its last trade with -8.23% loss, and closed at $64.41.
Ambarella declared that Dr. Fermi Wang, CEO, and George Laplante, CFO, will present at the Deutsche Bank Technology Conference on Wednesday, Sept. 16th at The Cosmopolitan hotel in Las Vegas.
Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
